Litigation

Andrew Frankel Named Among 2024 Law360 Insurance MVPs for Pioneering Litigation Work

by

New York, NY — Andrew Frankel, the lead attorney of Simpson Thacher & Bartlett LLP’s insurance and reinsurance practice, has successfully navigated multiple high-stake coverage disputes, positioning him among the top industry experts in the 2024 Law360 Insurance MVPs. His adept representation in areas ranging from environmental claims like PFAS cases to complex product liability disputes involving talc injury claims against Johnson & Johnson sets him apart in the legal landscape. Frankel’s expertise extends to intricate receivership matters within the challenging terrain of South Carolina asbestos litigation. His ability to effectively manage and litigate these … Read more

Exploring the Evolution of Litigation Finance: From Niche Market to $15 Billion Industry at LitFinCon

by

Los Angeles, CA — Once considered a niche sideline of the financial world, litigation finance has surged into prominence, transforming into a robust $15.2 billion industry, marking a significant rise from $9.5 billion just five years earlier. This growth trajectory was highlighted at the recent LitFinCon, hosted by Siltstone Capital in Los Angeles, which brought together funders, investors, lawyers, bankers, and judges to discuss the sector’s evolution and current issues. At the conference, a history of litigation funding was recapped, reflecting its journey from dubious legality to a mainstream finance tool. Initially, the practice faced … Read more

Expert in Pharma Patents, Judge Martinotti Takes on Key ANDA Litigation Cases in New Jersey

by

TRENTON, N.J. — Judge Martinotti, a presiding figure in the U.S. District Court for New Jersey, brings a rich background of experience to the bench, particularly in intricate legal battles related to pharmaceutical patents and ANDA litigation. His tenure has distinguished him as a notable jurist in the field of intellectual property rights, where stakes are particularly high due to the profound impact these decisions can have on healthcare costs and access to medicine. Martinotti’s rulings have often provided clarity in the murky waters of generic and branded pharmaceutical interactions, which are governed by the … Read more

Rep. Comer Calls on Chief Justice Roberts to Enforce Transparency in the $15 Billion Litigation Finance Industry

by

Washington, D.C. – The debate around the transparency of litigation finance has reached a new peak as Representative James Comer (R-Ky.), head of the House Committee on Oversight and Accountability, recently called on Chief Justice John Roberts to intervene. Comer’s request urges the Judicial Conference to consider instituting rules for the mandatory disclosure of external funding in federal lawsuits, citing concerns over potential conflicts of interest and the influence of foreign investments. Rep. Comer expressed concerns that understanding the specifics of litigation funding – including the sources and financial terms – is crucial for informed … Read more